Un estudio del IDIS abre la puerta a nuevos biomarcadores y estrategias para la esquizofrenia resistente al tratamiento

Se trata de un paso importante hacia la mejora del diagnóstico, seguimiento y tratamiento de la esquizofrenia resistente al tratamiento.

Publicado por IJMS (International Journal of Molecular Sciences), ha sido uno de los artículos más descargados en 2023, según informa la publicación.

La dieta atlántica reduciría significativamente el riesgo de sufrir síndrome metabólico

Un estudio realizado por personal investigador del IDIS y publicado en la revista científica JAMA Network constata los beneficios de la dieta atlántica para reducir el síndrome metabólico que afecta al 25% de la población adulta.

Los cambios en la dieta representan una estrategia clave para prevenir millones de muertes en todo el mundo cada año.

News

Calendar

05 February 2024 February 5 - March 22
Load More

COMMON SUPPORT PLATFORMS

The platforms are research support units featured by a high strategic value, equipped by cutting edge technologies and operated by highly specialised technical staff.

CALLS

All updated information on public and private competitive calls. The most convenient and safest way to send your requests.

CAREERS

Would you like to join our team? We are always looking for people with a passion for research and propelled by insatiable curiosity to join our mission of providing a better healthcare day every day. Here you can see and apply for our current vacancies.

Research Areas

ONCOLOGY

Improvement of treatments: personalised therapy and reduction of side effects.

GENETICS AND SYSTEMS BIOLOGY

Identification of genetic biomarkers of disease susceptibility and prognosis

ENDOCRINOLOGÍA, NUTRICIÓN Y METABOLISMO

The area studies obesity from different perspectives with the participation of groups from the clinical and basic fields in a synergistic way.

NEUROSCIENCES

Search for new therapeutic targets and improvement of the clinical-therapeutic management of neurological patients, mainly stroke, Alzheimer’s, Parkinson’s disease, headaches and neurological diseases caused by prions.

CARDIOVASCULAR

The general objective of the Cardiovascular Area consists of the search for new therapeutic targets and the improvement of clinical-therapeutic management.

PLATFORMS AND METODOLOGY

The area aims at providing evidence for prioritising the management of public resources, evaluating risks and identifying opportunities for improving the health of the population. From here, prioritise structural investments and action programs.